Lymphopain, a cytotoxic T and natural killer cell-associated cysteine proteinase

Leukemia

Volumn 12, Issue 11, 1998, Pages 1771-1781

  Brown, J ^a   Matutes, E ^b   Singleton, A ^c   Price, C ^a   Molgaard, H ^a   Buttle, D ^c   Enver, T ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Cell killing; Cysteine proteinase; LGL leukaemia; Lymphopain; T lymphocytes

Indexed keywords

CYSTEINE PROTEINASE; LYMPHOCYTE ENZYME; LYMPHOPAIN; PAPAIN; UNCLASSIFIED DRUG;

ARTICLE; CHROMOSOME 11Q; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; ENZYME ACTIVITY; ENZYME LOCALIZATION; GENE MAPPING; HUMAN; HUMAN CELL; MOLECULAR CLONING; NATURAL KILLER CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

EID: 0031785963     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401164     Document Type: Article

References (27)

1. Rawlings N, Barrett A. Families of cysteine peptidases. Meth Enzymol 1994; 244: 461-486.
2. Berti PJ, Storer AC. Alignment/phylogeny of the papain superfamily of cysteine proteases. J Mol Biol 1995; 246: 273-283.
3. Kirschke H, Barrett AJ, Rawlings ND. Proteinases 1: lysosomal cysteine proteinases. In: Sheterline P (ed). Protein Profiles, vol 2. Academic Press: London, 1995, pp 1588-1643.
4. Riese RJ, Wolf PR, Bromme D, Natkin LR, Villadangos JA, Ploegh HL, Chapman HA. Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading. Immunity 1996; 4: 357-366.
5. Bromme D, Okamoto K, Wang BB, Biroc S. Human cathepsin O2, a matrix protein-degrading cysteine protease expressed in osteoclasts. Functional expression of human cathepsin O2 in Spodoptera frugiperda and characterization of the enzyme. J Biol Chem 1996; 271: 2126-2132.
6. Furukawa T, Yang Y, Nakamoto B, Stamatoyannopoulos G. Identification of new genes expressed in a human erythroleukemia cell line. Blood Cells Molec Dis 1996; 22: 11-22.
7. Enver T, Zhang J-W, Anagnou NP, Stamatoyannopoulos G, Papayannopoulou T. Developmental programs of human erythroleukaemia cells: globin gene expression and methylation. Mol Cell Biol 1988; 8: 4917-4926.
8. Koeffler H, Golde D. Acute myelogenous leukemia: a human cell line responsive to colony-stimulating activity. Science 1978; 200-1153-1155.
9. Koeffler H, Billing R, Lusis J, Sparkles R, Golde D. An undifferentiated variant derived from the human acute myelogenous leukemia cell line (KG-1). Blood 1980; 56: 265-273.
10. Furley A, Reeves B, Mizutani S, Altass L, Watt S, Jacob M, van den Elsen P. Divergent molecular phenotypes of KG1 and KG1a myeloid cell lines. Blood 1986; 68: 1101-1107.
11. Lozzio B, Lozzio C, Bamberger E, Feliu A. A multipotential leukemia cell line (K562) of human origin. Proc Soc Exp Biol Med 1981; 166: 546-551.
12. Schindler C, Fu X-Y, Improta T, Aebersold R, Darnell Jr J. Proteins of transcription factor ISGF-3: one gene encodes the 91- and 84-kDa ISGF-3 proteins that are activated by interferon α. Proc Natl Acad Sci USA 1992; 89: 7836-7839.
13. Dahl C, Schall R, He H, Cairns J. Identification of a novel gene expressed in activated natural killer cells and T cells. J Immunol 1992; 148: 597-603.
14. Trinchieri G. Biology of natural killer cells. Adv Immunol 1989; 47: 187-386.
15. Karrer KM, Peiffer SL, Di Tomas ME. Two distinct gene subfamilies within the family of cysteine protease genes. Proc Natl Acad Sci USA 1993; 90: 3063-3067.
16. Groves MR, Taylor MAJ, Scott M, Cummings NJ, Pickersgill RW, Jenkins JA. The prosequence of procaricain forms an α-helical domain that prevents access to the substrate-binding cleft. Structure 1996; 4: 1193-1203.
17. Coulombe R, Grochulski P, Siviraman J, Menard R, Mort JS, Cygler M. Structure of human procathepsin L reveals the molecular basis of inhibition by the prosegment. EMBO J 1996; 15: 5492-5503.
18. Souza CM, Hirai J, Mehta DP, Freeze HH. Identification of two novel dictyostelium discoideum cysteine proteinases that carry N-acetylglucosamine-1-P modification. J Biol Chem 1995; 270: 28938-28945.
19. Baker EN, Drenth J. The thiol proteases: structure and mechanism. In: Jurnak FA (ed). Biological Macmmolecules and Assemblies. Active Sites of Enzymes, vol 3. John Wiley: New York, 1987, pp 314-368.
20. Enzyme Nomenclature 1992. Recommendations of the Nomenclature Committee of the IUBMB. Academic Press: San Diego, 1992.
21. O'Hara BP, Hemmings AM, Buttle DJ, Pearl LH. Crystal structure of glycyl endopeptidase from Carica papaya: a cysteine endopeptidase of unusual substrate specificity. Biochemistry 1995; 34: 13190-13195.
22. Fox T, Mason P, Storer AC, Molt JS. Modification of S1 subsite specificity in the cysteine protease cathepsin B. Protein Eng 1995; 8: 53-57.
23. Vernet T, Berti P, de Montigny C, Musil R, Tessier D, Ménard R, Magny M-C, Storer A, Thomas D. Processing of the papain precursor. The ionization state of a conserved amino acid motif within the pro region participates in the regulation of intramolecular processing. J Biol Chem 1995; 270: 10838-10846.
24. Keppler D, Waridel P, Abrahamson M, Bachmann D, Berdoz J, Sordat B. Latency of cathepsin B secreted by human colon carcinoma cells is not linked to secretion of cystatin C and is relieved by neutrophil elastase. Biochim Biophys Acta 1994; 1226: 117-125.
25. Vernet T, Khouri H, Laflamme P, Tessier D, Musil R, Gour-Salin B, Storer A, Thomas D. Processing of the papain precursor. Purification of the zymogen and characterization of its mechanism of processing. J Biol Chem 1991; 266: 21451-21457.
26. Burnett D, Abrahamson M, Devalia J, Sapsford R, Davies R, Buttle D. Synthesis and secretion of procathepsin B and cystatin C by human bronchial epithelial cells in vitro: modulation of cathepsin B activity by neutrophil elastase. Arch Biochem Biophys 1995; 317: 305-310.
27. Smyth MJ, Trapani JA. Granzymes: exogenous proteinases that induce target cell apoptosis. Immunol Today 1995; 16: 202-206.